๐ฃ Residents and students, interested in @umresfelrx residency and fellowship programs? Come join us at our virtual residency and fellowship open houses via @zoom_us
! #TwitteRx#PharmRes
To learn more, register here: https://t.co/ahyaaMaA5W
@namorrismd@JAMACardio@JAMANetwork Solid framework for initiating therapy! Plus we can start working on insurance authorizations earlier to ensure patients can continue to receive after leaving the hospital.
IV glibenclamide shows promise for reducing cerebral edema and appears to be safe. PO glyburide leads to more hypoglycemia, especially if abnl renal fxn. Smaller, more frequent dosing may help. Kudos to @MikeA_42 for pushing this through to publication. https://t.co/ux27nTQh0c
IV glibenclamide shows promise for reducing cerebral edema and appears to be safe. PO glyburide leads to more hypoglycemia, especially if abnl renal fxn. Smaller, more frequent dosing may help. Kudos to @MikeA_42 for pushing this through to publication. https://t.co/ux27nTQh0c
Until our field recognizes that foley "for strict Is/Os" is rarely indicated and that not all positive UAs or even cultures deserve treatment, UTI rates will remain the same. You don't need a foley to treat a SAH! @MikeA_42#neurocrit
Interested in attending one of our upcoming recruitment events? Fill out this form to register: https://t.co/ahyaaLSZeo! We will be providing more information about upcoming @umresfelrx Zoom open houses soon! #PharmRes @TwitteRx
NEW ๐ฅ๐ฅ #AAC
CSF penetration of ceftolozane/tazobactam in critically ill pts w an indwelling EVD
The current maximal dose of C/T (3.0 g 8-hourly) does NOT provide adequate CSF exposure for treatment of G- meningitis or ventriculitis unless MIC โค0.25
https://t.co/LGlYKVz4GN
Welcome to our twitter for the University of Maryland Pharmacy Residency and Fellowship Programs! Please stay tuned for more info about our current residents, programs, Zoom open houses, and more! @umsop